Loop Capital analyst Joseph France raised the firm’s price target on UnitedHealth to $590 from $575 and keeps a Buy rating on the shares. The analyst is citing the company’s "strong" Q4 results and 2023 outlook. While the management’s guidance, detailed only six weeks ago at the UnitedHealth Investor, is unchanged, it is "no less remarkable" given last year’s tough comparison, France tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNH:
- UNH Little Changed after Beating Earnings and Reaffirming Guidance
- UnitedHealth expects to have more than 750 community pharmacies by 2023E
- UnitedHealth backs FY23 adjusted EPS view $24.40-$24.90, consensus $24.94
- UnitedHealth reports Q4 adjusted EPS $5.34, consensus $5.17
- Notable companies reporting before tomorrow’s open
